Product Description
Anastrozole (INN) (marketed under the trade name Arimidex by AstraZeneca) is a non-steroidal aromatase -inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastaisis in both pre and post-menopausal women. The severity of breast cancer can be increased by estrogen. as sex hormones cause hyperpiasia, and differentiation at estrogen receptorsites
Specification
Anastrozole
Alias: Arimidex,Tablets
Assay: 99.5%
Grade : Pharmaceutical Grade
Character: White crystalline powder
Storage: Shading, confined preservation
Drug Class: Injectable Anabolic Androgenic Steroid
Application:
1. Promote protein synthesis, inhibit protein heterogenesis, maintain the balance of n, increase appetite, muscle growth and weight gain.
2. Promote the deposition of calcium and phosphorus in bone tissue, promote the formation of interstitial bone cells, and accelerate the calcification and bone growth.
3. Promote tissue regeneration and granulation formation, and accelerate wound and ulcer repair.
4. Reduce blood cholesterol and improve lipid metabolism.